Literature DB >> 34782727

Predicting 1p/19q co-deletion status from magnetic resonance imaging using deep learning in adult-type diffuse lower-grade gliomas: a discovery and validation study.

Jing Yan1,2, Shenghai Zhang3, Qiuchang Sun3, Weiwei Wang2,4, Wenchao Duan5, Li Wang4, Tianqing Ding3, Dongling Pei5, Chen Sun5, Wenqing Wang5, Zhen Liu5, Xuanke Hong5, Xiangxiang Wang5, Yu Guo5, Wencai Li4, Jingliang Cheng1, Xianzhi Liu5, Zhi-Cheng Li6, Zhenyu Zhang7,8.   

Abstract

Determination of 1p/19q co-deletion status is important for the classification, prognostication, and personalized therapy in diffuse lower-grade gliomas (LGG). We developed and validated a deep learning imaging signature (DLIS) from preoperative magnetic resonance imaging (MRI) for predicting the 1p/19q status in patients with LGG. The DLIS was constructed on a training dataset (n = 330) and validated on both an internal validation dataset (n = 123) and a public TCIA dataset (n = 102). The receiver operating characteristic (ROC) analysis and precision recall curves (PRC) were used to measure the classification performance. The area under ROC curves (AUC) of the DLIS was 0.999 for training dataset, 0.986 for validation dataset, and 0.983 for testing dataset. The F1-score of the prediction model was 0.992 for training dataset, 0.940 for validation dataset, and 0.925 for testing dataset. Our data suggests that DLIS could be used to predict the 1p/19q status from preoperative imaging in patients with LGG. The imaging-based deep learning has the potential to be a noninvasive tool predictive of molecular markers in adult diffuse gliomas.
© 2021. The Author(s), under exclusive licence to United States and Canadian Academy of Pathology.

Entities:  

Mesh:

Year:  2021        PMID: 34782727     DOI: 10.1038/s41374-021-00692-5

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  2 in total

1.  A novel fully automated MRI-based deep-learning method for classification of 1p/19q co-deletion status in brain gliomas.

Authors:  Chandan Ganesh Bangalore Yogananda; Bhavya R Shah; Frank F Yu; Marco C Pinho; Sahil S Nalawade; Gowtham K Murugesan; Benjamin C Wagner; Bruce Mickey; Toral R Patel; Baowei Fei; Ananth J Madhuranthakam; Joseph A Maldjian
Journal:  Neurooncol Adv       Date:  2020-07-17

Review 2.  Artificial intelligence in cancer imaging: Clinical challenges and applications.

Authors:  Wenya Linda Bi; Ahmed Hosny; Matthew B Schabath; Maryellen L Giger; Nicolai J Birkbak; Alireza Mehrtash; Tavis Allison; Omar Arnaout; Christopher Abbosh; Ian F Dunn; Raymond H Mak; Rulla M Tamimi; Clare M Tempany; Charles Swanton; Udo Hoffmann; Lawrence H Schwartz; Robert J Gillies; Raymond Y Huang; Hugo J W L Aerts
Journal:  CA Cancer J Clin       Date:  2019-02-05       Impact factor: 508.702

  2 in total
  1 in total

1.  Swin Transformer Improves the IDH Mutation Status Prediction of Gliomas Free of MRI-Based Tumor Segmentation.

Authors:  Jiangfen Wu; Qian Xu; Yiqing Shen; Weidao Chen; Kai Xu; Xian-Rong Qi
Journal:  J Clin Med       Date:  2022-08-08       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.